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Reverse-phase chromatographic determination 
and intrinsic stability behavior of 5-[(4-chlorophenoxy)methyl]-
-1,3,4-oxadiazole-2-thiol
The study describes the development and preliminary valida-
tion of a simple reverse-phase chromatographic method for 
determination of a novel drug candidate, 5-[(4-chlorophenoxy)
methyl]-1,3,4-oxadiazole-2-thiol (OXCPM), in bulk and 
stressed solution, in order to find out the intrinsic stabi lity 
behavior of the compound. Isocratic elution was carried out 
at a flow rate of 1.0 mL min–1 through a Promosil C18 column 
maintained at 25 °C, using the mobile phase comprising 
acetonitrile and aqueous o-H3PO4 (pH 2.67) (1:1, V/V). Detec-
tion was performed at 258 nm. The response of the detector 
was linear in a concentration range of 1.25–50.00 µg mL–1 
with the correlation coefficient of 0.9996 ± 0.0001. Cumulative 
intra-day, inter-day and inter-instrument accuracy (99.5 ± 1.0, 
100.2 ± 1.0 and 100.3 ± 0.4 %, resp.) with RSD less than 5 % 
indicated that the method was accurate and precise. The 
resolution and selectivity factor (>2 and >1, resp.), particularly 
in copper metal- and dry-heat-stress solutions, depicted the 
selectivity of the method. OXCPM remained stable under 
hydrolytic (acidic and neutral pH, ≤ 37 °C), photolytic and 
moist heat stress conditions. Under alkaline conditions 
(hydrolytic and photolytic), polar products were formed that 
eluted very fast through the column (tR < 3.75 min). At room 
temperature, the compound was susceptible to oxidation by 
hydrogen peroxide and transition metals. The ionogram of 
most of the stress solutions indicated the presence of a 
product having m/z 256, which might be a result of N- or S- 
methylation or -SH oxidation. The results of the study 
indicate that the method is selective, sensitive and suitable 
to be used for determination of OXCPM in bulk and under 
stress conditions.
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5-[(4-Chlorophenoxy)methyl]-1,3,4-oxadiazole-2-thiol (OXCPM) (Fig. 1) was synthesis 
to be used as a precursor for a number of less cytotoxic antimicrobial and antienzymatic 
derivatives (1). The compound is a 2,5-disubstituted oxadiazole, which is an important 
heterocyclic active moiety – pharmacophore – due to the presence of cyclic nitrogen (2 atoms) 
and oxygen (one atom) and exocyclic sulfur (2). Several agents possessing such pharmaco-
phore have been found effective against a number of diseases including cancer, hyperten-
sion, arrhythmia, CNS depression and retroviral and bacterial infections (3–6). Keeping 
this in mind, we have investigated this parent compound for drug likeliness and found it 
a potential candidate for drug development (7).
For quantification of OXCPM in bulk and matrices, a simple and specific chromato-
graphic method is needed. Therefore, the present study describes for the first time the 
development and validation of a reverse-phase chromatographic method for determina-
tion of OXCPM.
Fig. 1. Structural formula of OXCPM.
EXPERIMENTAL
Chemicals, reagents and other supplies
Analytical grade sodium hydroxide pellets, copper(II) sulphate pentahydrate, iron(II) 
sulphate heptahydrate, magnesium sulphate heptahydrate, hydrogen peroxide solution (35 
%), fuming hydrochloric acid (37 %) and sodium dihydrogen phosphate were purchased 
from Merck (Germany), trifluoroacetic acid from Scharlab (Spain), ortho-phosphoric acid 
(85 %) from BDH Chemicals (UK), HPLC grade methanol from Duksan Pure Chemicals (S. 
Korea) and acetonitrile from Tedia Company (USA). Polytetrafluoroethylene membrane 
syringe filters (0.2 µm, Minisart SRP 15, Sartorius Stedim Biotech, Germany) and nylon-H 
filters (0.45 µm, Micropore, USA) were used. OXCPM was received as a gift from the De-
partment of Chemistry, GCU, Lahore, Pakistan, the synthesis and characterization of 
witch is already reported (1). The in-house prepared ultrapure water was used throughout 
the study.
Instrumentation
Two HPLC systems were used to develop and validate the method: HPLC system 1200 
series (Agilent Technologies, Germany), equipped with an isocratic pump (G1310 A), auto-
sampler (G1329 A), column thermostat (G1316 A), diode array detector (G 1315 B) and 
operating software (Agilent ChemStation LC/LCMS for Windows, Rev. B.01.03 [204]), and 
a binary HPLC system (Series 200-LC Pump, PerkinElmer, USA), equipped with a gradient 
pump (291N6112805A), manual injection port, UV/Vis-detector (292N6110902A) and ope rat-
ing software (PerkinElmer TotalChrom Workstation, version 6.3.2).
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Columns used during method optimization included Promosil C18 (5 µm, 4.60 × 250 
mm), Eclipse X DB-C18 and Zorbax SB-C18 (5 µm, 4.60 × 150 mm). In addition, a gas chro-
matograph equipped with a mass spectrophotometer (GC-MS-qp 2010, Shimadzu, Japan) 
and capillary column (J&W DB 5MS, 30 m × 0.25 mm ID, Agilent, USA) was used. A UV 
lamp (UVGL-58, USA), sonicator (DSA50-SK1-1.8L, Germany), thermostatic oven (U10, 
Memmert, Germany), pH meter (Hanna Instruments, Romania), stability chamber (Curio, 
SC-0709) and ultra-low chiller (Curio, MOF U32V) of Sanyo Electric Corporation, Japan, 
were used.
Method development and optimization
Preparation of mobile phases. – Mobile phases used during the development and optimi-
zation of the method included methanol, water, acetonitrile, acetonitrile/water (1:1, V/V), 
acetonitrile/sodium dihydrogen phosphate buffer (pH 4.47) (1:4 and 1:1, V/V), acetonitrile/
water/phosphoric acid (50:48:2, V/V), acetonitrile/water/trifluoroacetic acid (50:48:2, V/V) 
and acetonitrile/aqueous o-H3PO4 (pH 2.67) (1:1, V/V). Mobile phases were filtered through 
a nylon membrane and degassed using an ultrasonicator.
Preparation of standard solutions. – A standard stock solution of the compound was 
prepared in methanol (1.00 mg mL–1). Then, a range of working standard solutions (1.25–
50.00 µg mL–1) were prepared by diluting the stock solution with the mobile phase, aceto-
nitrile/aqueous o-H3PO4 (pH 2.67) (1:1, V/V).
Chromatographic conditions. – A sample volume (20 µL) was eluted through a Promosil 
C18 column (5 µm, 4.60 × 250 mm) isocratically using the mobile phase composed of aceto-
nitrile and o-H3PO4 (pH 2.67) (1:1, V/V) at a flow rate of 1.0 mL min–1. The temperature of 
the column was maintained at 25 °C and detection was carried out at 258 nm using DAD.
System suitability. – Chromatographic parameters, i.e., the number of theoretical plates 
(N), height equivalent to the theoretical plate (HETP), reduced plate height, capacity factor 
(k/), tailing factor and peak asymmetry (As), were evaluated to ensure that the system was 
working accurately during the analysis (8).
Method validation
The developed method was validated according to the available guidelines and pro-
tocols (9, 10). Validation parameters are summarized as follows.
Linearity and Beer’s range. – Twelve working standard solutions (1.25–50.00 µg mL–1) 
were analyzed in triplicate, using the chromatographic conditions described above. Line-
arity was assessed from the plot of peak area (mAU s) versus concentration (µg mL–1) by 
the linear regression analysis. Beer’s range was established from the linearity studies.
Limit of detection (LOD) and limit of quantification (LOQ). – Working standard solutions 
of 1.25–50.00 µg mL–1 concentration were analyzed in quintuplicate and five standard 
curves were constructed from the obtained data. Sensitivity parameters – limit of detec-
tion (LOD) and limit of quantification (LOQ) – were determined statistically from the stan-
dard deviation of the intercept and mean slope of the calibration line (10). 
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Accuracy and precision. – Three concentration levels (1.25, 25.00 and 50.00 µg mL–1) of 
working standard solutions were used to determine the accuracy and precision. Intra- and 
inter-day accuracy and precision were assessed by analyzing these concentrations 6 times 
in a single day and once daily for six consecutive days, and determining their amounts 
from calibration curves constructed on each day. Intermediate accuracy/precision of the 
developed method was assessed by performing the experiments on two different instru-
ments and calculating the amounts of the compound from the calibration curve.
Specificity and selectivity. – Specificity of the assay towards OXCPM was determined by 
resolution (Rs) and the selectivity factor (α) of the OXCPM peak and the nearest peak in the 
stressed solution (prepared as mentioned below), if any.
Robustness. – The effect of small deliberate changes in column temperature, detection 
wavelength, mobile phase composition, sample preparation and pH on OXCPM accuracy 
determination was investigated to establish the robustness of the method.
Sample solution stability. – Stability of the working standard solution (50.00 µg mL–1) 
was evaluated by storing the samples in screw-capped test tubes, protected from light at 
room temperature, in a refrigerator and freezer for 48 h. The content was compared with 
the freshly prepared solution.
Intrinsic stability behavior under stress conditions
Intrinsic stability behavior of the compound was assessed through forced degrada-
tion studies. Experimental conditions used in the study complied with the standard guide-
lines and previously published reports (11–14). Methanolic solution of OXCPM (200.00 µg 
mL–1) was subjected to hydrolytic, oxidative, photolytic, transition metal and thermal 
stresses. For each stress condition, four samples were generated, i.e., sample solution (real 
time and stressed) and blank (real time and stressed). Samples were withdrawn after a 
suitable period of time, neutralized (if needed), filtered, diluted in the mobile phase to a 
suitable concentration and subjected to HPLC analysis. A brief account of the procedure is 
given below.
For hydrolytic stress at acidic, alkaline and neutral pH, the sample solution was sepa-
rately treated with equal volumes of 0.10, 1.00 and 5.00 mol L–1 HCl, 0.10, 1.00 and 5.00 mol 
L–1 NaOH and water, resp. Two such sets were prepared and heated at 37 ± 5 and 121 ± 5 
°C for 24 and 1 h, resp. For oxidative stress, equal volumes of the sample and hydrogen 
peroxide solution (1, 3, 10 and 20 %) were stored at room temperature for a period of 28 h. 
For photolytic stress, sample solutions in 0.10 mol L–1 HCl, 0.10 mol L–1 NaOH and water 
were separately placed for 48 h in UV (254 nm) and visible light (sunlight, 60,000 to 70,000 
lux and tungsten lamp, 100 Watt for 12 h alternatively), whereas suitable controls were kept 
in dark for the same time. For transition metal stress, OXCPM solutions were mixed with 
equal volumes of 1.50 mmol L–1 of copper, iron and magnesium solutions and stored for 
28 h at room temperature. The effect of dry and moist heat on the aqueous solution of 
OXCPM was observed by placing it in a hot-air oven at 150 ± 10 °C and in a stability chamber, 
maintained at 60 ± 5 °C and 90 % relative humidity (RH), for 48 h, resp. As a control, OXCPM 
solution was placed in a refrigerator (2–8 °C), a chiller (–52 ± 5 °C) and at room temperature 
for the same period of time.
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Identification of degradation products
The injection volume of 1 µL (split mode with 90 % split ratio) was eluted through a 
silica capillary column (0.25 µm, coating 5 % phenyl polysiloxane) with helium at a flow 
rate of 1.27 mL min–1. Column temperature was initially kept at 40 °C for 5 min, raised to 
180 °C (at a heating rate of 5 °C min–1) and finally to 240 °C (at a heating rate of 3 °C min–1) 
and kept there for 5 min. The temperature of the injection port was maintained at 200 °C. 
The mass detector was operated in the electron-impact ionization mode (ionization energy, 70 
eV). Molecular ion peaks were identified and possible structures were drawn on the basis 
of already reported data on decomposition pattern/chemical reactions of functional groups 
in OXCPM (14–19).
RESULTS AND DISCUSSION
HPLC-DAD method development and optimization
Based on the UV profile of OXCPM, detection was carried out at two wavelengths, 223 
and 258 nm, using DAD. However, method validation was performed at the latter since the 
solvents/mobile phases did not absorb in this range and also because the response of the 
detector showed a wider linearity range at this wavelength. OXCPM was analyzed using 
three types of C18 columns (5 µm, 4.60 × 250 mm) and elution was carried out by varying 
the column temperature (25 ± 5 °C). However, elution through Promosil C18 at 25 °C 
provided the best results.
Several types of mobile phases were investigated in order to achieve suitable peaks. 
Moreover, changes of pH of the mobile phase (2.67 ± 2) and the flow rate (1.0 ± 0.5 mL 
min–1) were made to improve retention time (tR) and peak symmetry. The optimum elution 







 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 13.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 2.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 3.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 4.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 5.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 6.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 7.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 8.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 9.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 10.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 11.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN 18-08-2015 LINEARITY\STANDARD 12.D)
Fig. 2. Overlay of the chromatograms of OXCPM in the concentration range of 1.25–50.00 µg mL–1.
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was achieved by the mobile phase composed of acetonitrile and aqueous o-H3PO4 (pH 2.67) 
(1:1, V/V) at a flow rate of 1.0 mL min–1 at 10.37 ± 0.01 min. Chromatograms of the compound 
obtained using the optimized chromatographic conditions are shown in Fig. 2, which 
show that the peaks are Gaussian.
Chromatographic parameters
The system suitability parameters were calculated based on the eluted peak of the 
OXCPM solution of 50.00 µg mL–1. Numerical data, shown in Table I, complied with the 
established guidelines (8), indicating the suitability of the method.
Method validation
Linearity and Beer’s range. – The coefficient of determination of 0.9996 ± 0.0001 indicated 
that the method was linear over the studied concentration range (1.25–50.00 µg mL–1). In 
the same context, the slope, y-intercept and residual sum of squares were found to be 55.15 
± 0.08 mAU s mL µg–1, 10.68 ± 0.26 mAU s and 3920.90, resp.
Limit of detection (LOD) and limit of quantification (LOQ). – The calibration range and 
linear regression equations used to calculate limiting values of the compound are shown 
in Table II. Limiting values of 0.016 µg mL–1 for LOD and 0.047 µg mL–1 for LOQ indicated 
that the method was sensitive and, hence, could be used for determination of OXCPM at 
the sub-microgram level.
Intra-day, inter-day and inter-instrument accuracy and precision. – Results of the accuracy 
and precision of the method are given in Table III. The cumulative intra-day, inter-day and 
inter-instrument accuracy (99.5 ± 1.0, 100.2 ± 1.0 and 100.3 ± 0.4 %, resp.) with RSD less than 
5 % indicated that the method was accurate and precise.
Specificity/selectivity. – The Rs and α of the OXCPM peak from the nearest peak, par-
ticularly in the copper metal- and dry-heat stress solutions (Figs. 7 and 8), were found to 
be >2 and >1, resp. These results indicated that the method was selective.
Table I. Chromatographic parameters
Parameter Value
Retention time (tR, min)a 10.37 ± 0.01
Capacity factor (k´) 4.0
Peak repeatability (RSD, %) 0.5
Tailing factor 1.0
Number of theoretical plates (N) 29024.6
Height equivalent to the theoretical plate (HETP) (µm) 8.6 
Reduced plate height (µm) 1.7 
Peak symmetry 1.0
a Mean ± SD (n = 6)
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Robustness. – The change in the volume of acetonitrile (± 2 mL) in the optimized mobile 
phase, pH of water (± 0.20), column temperature (± 2 oC), detection wavelength (± 5 nm) and 
sample solvent (methanol and mobile phase) did not affect accuracy, and hence the method 
was robust (Table IV).
Sample solution stability. – Recovery of OXCPM from the solutions stored at room tem-
perature, in the refrigerator and in the freezer was 100.4 ± 0.6, 97.1 ± 1.2 and 101.1 ± 0.1 %, 
resp. These results indicated that the sample can be analyzed accurately for 48 h after 
preparation. 
Intrinsic stability behavior under stress conditions
Hydrolytic stress. – Hydrolytic decomposition of OXCPM in acidic, alkaline and neutral 
solutions is shown in Fig. 3. The compound was extensively hydrolyzed in solutions of var-
ious pH at 121 ± 5 oC. The degradation pattern indicated by the appearance of additional 
peaks was different under three acid stress conditions. With an increase in acidity, the per-
centage of degradation and the number of degradation products increased. The maximum 
number of degradation products was observed in 5 mol L–1 HCl, which eluted at 4.45 ± 0.00, 
4.77 ± 0.02, 5.38 ± 0.06, 7.03 ± 0.20, 7.65 ± 0.01 and 8.97 ± 0.00 min. Major degradation peaks in 
all acidic stress solutions were observed at 7.26 ± 0.37 and 8.97 ± 0.00 min (Fig. 3b). On the 
other hand, under all three alkaline conditions, the degradation pattern was similar. Highly 




determination (R2) Slope Intercept
1.25–50.00 0.9996 ± 0.0001a 55.15 ± 0.08a 10.68 ± 0.26a
LOD = 0.016µg mL–1
LOQ = 0.047 µg mL–1
S – slope of calibration line, σ – standard deviation of line intercept, LOD (limit of detection) = 3.3 (σ/S), LOQ 
(limit of quantification) = 10 (σ/S), ref. 10
a Mean ± SD (n = 5).









  1.25   99.3 ± 0.5   99.9 ± 0.6 100.0 ± 0.1
25.00 100.4 ± 0.6 100.5 ± 1.3 100.8 ± 0.2
50.00   98.7 ± 0.9 100.1 ± 1.2 100.1 ± 0.1
a Mean ± SD, n = 6.
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polar products were retained in the column for only a few minutes and no OXCPM peak was 
observed (Fig. 3d). In neutral solution, degradation gave rise to three degradation products 
that eluted at 4.64 ± 0.01, 5.28 ± 0.01 and 6.31 ± 0.10 min. A major peak was observed at 6.31 ± 
0.10 min, which demonstrated the fronting phenomenon (Fig. 3f). It is worth mentioning 
here that upon storage of the solutions at ambient temperature (37 ± 5 °C) for 24 h, OXCPM 
did not show any decomposition at acidic or neutral pH (Figs. 3a, e). However, in 0.10 mol L–1 
NaOH, OXCPM degradation was 44.59 ± 0.10 %, and upon increasing alkalinity, a similar 
degradation pattern to that indicated at high temperature was observed (Fig. 3d). These re-
sults clearly indicate that OXCPM was susceptible to degradation at alkaline pH regardless 
of the temperature. However, at acidic and neutral pH, temperature played the primary role.
Oxidative stress. – OXCPM was extensively oxidized by hydrogen peroxide (Fig. 4); how-
ever, the extent of decomposition and degradation products did not increase with the in-
crease in oxidant concentration (1–20 %). Degradation peaks eluted at 4.57 ± 0.03 and 7.15 ± 
0.11 min. These results indicated that OXCPM was liable to oxidation at room temperature 
with strong oxidants, which might be due to the presence of a thiol group in the structure.
Photolytic stress. – In neutral solutions, OXCPM was found to be quite stable under both 
UV and visible light whilst in acidic solution, it showed slight degradation (6.68 ± 0.01 %) 
without any additional peak formation. In contrast, under alkaline conditions, the com-
Table IV. Robustness of OXCPM determination under slightly changed chromatographic conditions
Chromatographic conditions Concentrationa (%)
Mobile phase
Acetonitrile/aqueous o-H3PO4 (pH 2.67) (52:48) 100.0 ± 0.1
Acetonitrile/aqueous o-H3PO4 (pH 2.67) (48:52)   99.2 ± 1.0
Column temperature (oC)
27   96.0 ± 1.9
23 100.0 ± 1.2
pH of water 
2.87 101.2 ± 0.1
2.47 100.2 ± 0.7
Detection wavelength (nm)
253 100.1 ± 0.9
263   99.8 ± 0.7
Sample solvent
Methanol 101.2 ± 0.8
Mobile phase 100.0 ± 0.02
                                   a Mean ± SD, n = 3.
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 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\AB1.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\AB2.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\AB3.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\AD1.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\AD2.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\AD3.D)









 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN HYDROLYTIC STRESS\HCL 1 B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN HYDROLYTIC STRESS\HCL 1 D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN HYDROLYTIC STRESS\HCL 2 B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN HYDROLYTIC STRESS\HCL 2 D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN HYDROLYTIC STRESS\HCL 3 B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN HYDROLYTIC STRESS\HCL 3 D.D)










 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\BB1.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\BB2.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\BB3.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\BD1.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\BD2.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\BD3.D)









DP in HCl 2 and 3
 
DP-HYD in NaOH 
1, 2 and 3
SP in NaOH 1
Fig. 3. Overlay of chromatograms of OXCPM after stress under different pH/temperature hydrolytic 
conditions: a) and b) acid hydrolysis at 37 ± 5 and 121 ± 5 °C, resp., in 0.10, 1.00 and 5.00 mol L–1 HCl 
(labeled as HCl 1, 2 and 3); c) and d) alkaline hydrolysis at 37 ± 5 and 121 ± 5 °C, resp., in 0.10, 1.00 and 
5.00 mol L–1 NaOH (labeled as NaOH 1, 2 and 3); e) and f) neutral hydrolysis (water) at 37 ± 5 and 
121 ± 5°C, resp. (labeled W).
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 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN BASIC HYDROLYSIS\NAOH 1 B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN BASIC HYDROLYSIS\NAOH 1 D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN BASIC HYDROLYSIS\NAOH 2 B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN BASIC HYDROLYSIS\NAOH 2 D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN BASIC HYDROLYSIS\NAOH 3 B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN BASIC HYDROLYSIS\NAOH 3 D.D)







 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\NB.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN AMBIENT\ND.D)









 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN NEUTRAL HYD\NEUTR HYR B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN NEUTRAL HYD\NEUTR HYR D.D)
DP-HYD in NaOH  







pound was extensively degraded under both UV and visible light and produced polar 
products (tR = 6.73 min) that rather quickly eluted from the non-polar column. Interest-
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drolytic conditions. The neutral solution of OXCPM stored in the dark showed no decom-
position (Fig. 5). These results indicated that the compound was photo-stable in acidic and 
neutral solutions only. It is worth mentioning that the behavior of OXCPM under visible-
light-stress was quite similar to that under UV-light, which meant that the type/intensity 
of electromagnetic radiation did not influence the stability of OXCPM markedly. 
Stress of transition metals. – In 1.50 mmol L–1 transition metal solutions, maximum 
decomposition was brought about by iron and magnesium, followed by copper. A major 
degradation peak in metal solutions was observed at 8.38 ± 0.04 min. In addition, another 
degradation product was observed in copper solution, which eluted at 6.52 ± 0.11 min 
(Fig. 6).
Thermal stress. – Decomposition of the compound was observed in dry heat at 150 ± 10 °C, 
whereby only 27.60 ± 0.04 % of OXCPM was recovered and three distinct peaks appeared 
at 4.10 ± 0.09, 5.02 ± 0.08 and 5.54 ± 0.00 min. Upon storage under moist heat at room tem-
perature, no degradation took place. Similarly, solutions stored in the refrigerator and 
chiller showed no instability. These results indicated that the aqueous solution of the com-
pound decomposed only in dry heat at high temperature and was stable in moist heat and 
at room temperature (Fig. 7).
Characterization of degradation products
Degradation products formed under different stress conditions were characterized 
using mass spectrometry and the findings were compared to the decomposition of the 
related compound/functional groups. Ionograms of almost all stress solutions indicated 
the presence of compounds having m/z 256 (Fig. 8).
In addition to the above, molecular ion (M+) peaks of m/z 213 and 169 were observed 
under acid hydrolysis, 482 in neutral hydrolysis, and 270 and 284 under alkaline hydrolysis 
Fig. 4. Overlay of chromatograms of OXCPM in oxidative stress solutions (1, 3, 10 and 20 % hydrogen 
peroxide).
SP – standard peak, DP-OXD – oxidative degradation product











 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PEAK PURITY\1% OXD B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PEAK PURITY\1% OXD SAMPLE.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PEAK PURITY\3% OXD B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PEAK PURITY\3% OXD SAMPLE.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PEAK PURITY\10% OXD B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PEAK PURITY\10% OXD SAMPLE.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PEAK PURITY\20% OXD B.D)




N. Shehzadi et al.: Reverse-phase chromatographic determination and intrinsic stability behavior of 5-[(4-chlorophenoxy)methyl]-
-1,3,4-oxadiazole-2-thiol, Acta Pharm. 68 (2018) 409–424.
 








 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\UV ACIDIC B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\UV ACIDIC D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\UV BASIC B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\UV BASIC D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\UV NEUT B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\UV NEUT D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\DARK B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\DARK D.D)








 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\VIS ACIDIC B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\VIS ACIDIC D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\VIS BASIC B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\VIS BASIC D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\VIS NEUT B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\VIS NEUT D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\DARK B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN PHOTOLYTIC STRESS\DARK D.D)
 DP-NaOH
SP in control, HCl and W
DP-NaOH
SP in control, HCl and W
Fig. 5. Overlay of chromatograms of OXCPM in photolytic stress solutions: a) UV-light; b) visible light. 
SP – standard peak, DP-NaOH – photolytic degradation product in alkaline solution, HCl – hydro-
chloric acid, W – water.
conditions. The possible structures corresponding to these molecular ion peaks are shown 
in Fig. 9. 
Thiols are easily oxidized compared to alcohols and such reactions result in changing 
the oxidation state (OS) of sulfur atom. The thiol group reacts with strong oxidants to yield 
sulfenic acid (OS = 0), sulfinic acid (OS = +2), sulfoxide (OS = 0), sulfones (OS = +2) or 
sulfonic acid (OS = +4); however, with mild oxidants, disulfides (OS = –1) are produced. In 
the case of hydrogen peroxide, the reaction at room temperature produces sulfoxides, which 
upon exposure to high temperatures (100 °C) are oxidized to sulfones. Mass spectrum of 
OXCPM stressed with hydrogen peroxide showed the presence of a compound having 
m/z 256. The structures corresponding to the product might be sulfenic acid or sulfoxide 
since the degradation was investigated at room temperature (A and B in Fig. 9) (14–18).
In the case of acidic, alkaline and neutral hydrolytic conditions, the compound having 
m/z 256 may represent the N- or S-methylated product (C and D). Compounds having m/z 
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 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN METAL STRESS\COPPER B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN METAL STRESS\COPPER D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN METAL STRESS\IRON B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN METAL STRESS\IRON D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN METAL STRESS\MAG B.D)














 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\DRY B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\DRY D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\MOIST B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\MOIST D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\RT B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\RT D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\FREEZ B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\FREEZ D.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\REF B.D)
 DAD1 A, Sig=258,70 Ref=360,100 (NAUREEN THERMAL STRESS\REF D.D)
 
SP in DH, MH, controls
DP-DH
Fig. 6. Overlay of the chromatogram of OXCPM in 1.50 mmol L–1 stress solution of heavy metals (iron, 
copper, magnesium). SP – standard peak, DP-MS – degradation product in magnesium solution, DP-
IS – degradation product in iron solution, DP-CS – degradation product in copper solution, SP-CS – 
standard peak in copper solution.
Fig. 7. Degradation behavior of OXCPM solution in dry heat. SP – standard peak, DP-DH – degrada-
tion product in dry heat at 150 ± 10 °C, MH – moist heat.
Fig. 8. The representative mass spectrum of the major degradation product of OXCPM having m/z 256.
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ation at N-3 in oxadiazole followed by ring cleavage, and des-sulfur derivative, resp. (E and 
F). At pH values of 7–9, two types of reactions, i.e., thiol oxidation and thiol-disulfide ex-
change, take place in aqueous solutions of thiol containing compounds (19). These reac-
tions take place in the presence of oxygen from air and do not require any other reagent. 
At neutral pH, the mass spectrum revealed the presence of the compound having m/z 480 
which may be the disulfide product (G). In alkaline solutions, peaks with m/z 270 and 284 
represent a product which may be formed as a result of base-catalyzed attachment of a 
methoxy group on the benzene ring and methylation at S-terminal (H and I) (Fig. 9) (20). 
It is worth mentioning that the photolytic degradation products in alkaline solutions were 
identical to those observed after basic hydrolysis. Moreover, in aqueous solutions, heat-
induced degradation products were similar to the ones observed at neutral and acidic pH.
CONCLUSIONS
The results of the present study reveal that the method developed for the analysis of 



























































Fig. 9. Chemical structures of possible products formed as a result of forced degradation of OXCPM.
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ICH prescribed stress conditions do not interfere in determination of OXCPM at 258 nm. 
Hence, the developed method is stability-indicating and may be applied for routine analy-
sis of the compound in bulk and stability studies. The intrinsic stability behavior of the 
compound suggests that the acidic and neutral solutions are resistant to hydrolysis at 
ambient temperature and photolysis under UV and visible light. However, alkaline solu-
tions were susceptible to both hydrolysis at mild-high temperatures and photolysis. Due 
to the thiol group, OXCPM showed extensive oxidative degradation in hydrogen peroxide 
and solutions of transition metals, which indicated that the compound might be having 
metal chelating and free radical scavenging potential.
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